BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9667513)

  • 1. Comparison of different labelling index formulae used on bromodeoxyuridine-flow cytometry data.
    Johansson MC; Johansson R; Baldetorp B; Oredsson SM
    Cytometry; 1998 Jul; 32(3):233-40. PubMed ID: 9667513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.
    Schultz-Hector S; Begg AC; Hofland I; Kummermehr J; Sund M
    Br J Cancer; 1993 Dec; 68(6):1097-103. PubMed ID: 8260360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal DNA synthesis in polyamine deficient cells revealed by bromodeoxyuridine-flow cytometry technique.
    Fredlund JO; Johansson M; Baldetorp B; Oredsson SM
    Cell Prolif; 1994 May; 27(5):243-56. PubMed ID: 10465009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
    Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E
    Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.
    Forster G; Cooke TG; Cooke LD; Stanton PD; Bowie G; Stell PM
    Br J Cancer; 1992 May; 65(5):698-702. PubMed ID: 1586597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of flow cytometric methods for determining population potential doubling times using cultured cells.
    Terry NH; White RA; Meistrich ML; Calkins DP
    Cytometry; 1991; 12(3):234-41. PubMed ID: 2036917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
    Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW
    Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry.
    Wilson GD; McNally NJ; Dische S; Saunders MI; Des Rochers C; Lewis AA; Bennett MH
    Br J Cancer; 1988 Oct; 58(4):423-31. PubMed ID: 3207597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell proliferation kinetics of six xenografted human cervix carcinomas: comparison of autoradiography and bromodeoxyuridine labelling methods.
    van Oostrum IE; Rozemuller E; Knol RF; Erkens-Schulze S; Rutgers DH
    Cell Tissue Kinet; 1990 Nov; 23(6):523-44. PubMed ID: 2276171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of mathematical formulas used for estimation of DNA synthesis time of bromodeoxyuridine-labelled cell populations with different proliferative characteristics.
    Johansson MC; Baldetorp B; Bendahl PO; Fadeel IA; Oredsson SM
    Cell Prolif; 1996 Oct; 29(10):525-38. PubMed ID: 9051116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate bromodeoxyuridine labelling of unseparated human bone marrow cells ex vivo is superior to labelling after routine laboratory processing.
    Jensen PO; Mortensen BT; Christensen IJ; Larsen JK
    Cell Prolif; 1998 Feb; 31(1):1-7. PubMed ID: 9666814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
    Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S
    Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].
    Margarino G; Scala M; Schenone G; Mereu P; Corvo R; Sanguineti G; Giaretti W; Geido E; Orecchia R; Meszaros P
    Acta Otorhinolaryngol Ital; 1992; 12(5):421-33. PubMed ID: 1303006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between potential doubling time (Tpot), labeling index and duration of DNA synthesis in 60 esophageal and 35 breast tumors: Is it worthwhile to measure Tpot?
    Haustermans K; Fowler J; Geboes K; Christiaens MR; Lerut A; van der Schueren E
    Radiother Oncol; 1998 Feb; 46(2):157-67. PubMed ID: 9510043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
    Tsang RW; Fyles AW; Kirkbride P; Levin W; Manchul LA; Milosevic MF; Rawlings GA; Banerjee D; Pintilie M; Wilson GD
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1319-29. PubMed ID: 7635771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
    Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
    Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal conditions for immunohistochemical determination of the in vitro DNA synthesis labelling index with bromodeoxyuridine in head and neck cancer.
    Browman GP; Kanclerz A; Booker L; Daya D; Archibald SD; Young JE; Goldsmith CH
    Cell Prolif; 1991 Nov; 24(6):579-85. PubMed ID: 1764538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific staining of iododeoxyuridine and bromodeoxyuridine in tumors double labelled in vivo: a cell kinetic analysis.
    Pollack A; Terry NH; Wu CS; Wise BM; White RA; Meistrich ML
    Cytometry; 1995 May; 20(1):53-61. PubMed ID: 7541331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling.
    Bertuzzi A; Faretta M; Gandolfi A; Sinisgalli C; Starace G; Valoti G; Ubezio P
    Bull Math Biol; 2002 Mar; 64(2):355-84. PubMed ID: 11926121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
    Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Barra S; Margarino G; Bacigalupo A; Vitale V
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1165-72. PubMed ID: 8262843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.